These findings highlight the relevance of transcriptional profiling to uncover genes linked to tumor aggressiveness, although additional studies are necessary to confirm the predictive value of DNMT3B and PFKFB4 in clinical settings. The gene discussed is PFKFB4; the disease is neoplasm.